Patent · 2024 · pending
Treatment of COLGALT2 Related Diseases and Disorders
siRNA and antisense oligonucleotides targeting COLGALT2, for conditions associated with COLGALT2 variants.
- Filings
- 1
- Status
- Pending
- First priority
- May 15, 2024
Patent · 2024 · pending
siRNA and antisense oligonucleotides targeting COLGALT2, for conditions associated with COLGALT2 variants.